Private Advisor Group, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 409 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
Private Advisor Group, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,191,347
+31.1%
22,753
+1.8%
0.01%
+14.3%
Q1 2024$908,832
+4.9%
22,341
-4.7%
0.01%0.0%
Q4 2023$866,750
+2.8%
23,451
+6.2%
0.01%
-12.5%
Q3 2023$843,227
-10.3%
22,074
+0.6%
0.01%0.0%
Q2 2023$939,654
+13.3%
21,944
+1.0%
0.01%0.0%
Q1 2023$829,372
-32.2%
21,7170.0%0.01%
-87.1%
Q4 2022$1,223,362
-25.9%
21,717
-48.0%
0.06%
+226.3%
Q3 2022$1,652,000
-10.1%
41,782
+0.0%
0.02%
+18.8%
Q2 2022$1,838,000
+10.3%
41,765
-0.0%
0.02%
+23.1%
Q1 2022$1,666,000
-0.9%
41,772
-0.1%
0.01%0.0%
Q4 2021$1,681,000
-50.4%
41,810
-49.8%
0.01%
-40.9%
Q3 2021$3,386,000
+78.8%
83,234
+99.6%
0.02%
+29.4%
Q2 2021$1,894,000
+9.0%
41,7000.0%0.02%0.0%
Q1 2021$1,738,000
+618.2%
41,700
+167.8%
0.02%
+325.0%
Q3 2019$242,000
-9.7%
15,570
-0.1%
0.00%
-20.0%
Q2 2019$268,000
+9.4%
15,587
+2.5%
0.01%0.0%
Q1 2019$245,000
+8.4%
15,210
-1.6%
0.01%0.0%
Q4 2018$226,00015,4650.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Third Security, LLC 14,092,771$206,177,00028.12%
BB BIOTECH AG 8,322,860$121,763,0003.90%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 398,633$4,579,0002.84%
DOHENY ASSET MANAGEMENT /CA 227,193$3,324,0002.43%
SNYDER CAPITAL MANAGEMENT L P 2,833,759$41,458,0002.24%
First Light Asset Management, LLC 938,399$13,729,0002.19%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,027,164$132,067,0001.77%
Taylor Wealth Management Partners 204,277$2,989,0001.72%
Sterling Global Strategies LLC 22,000$321,860,0001.63%
Granite Investment Partners, LLC 988,939$14,468,0001.06%
View complete list of HALOZYME THERAPEUTICS INC shareholders